Safety, Tolerability and Efficacy of the Depigmented Modified Allergen Extract of Two Mites in Subjects With Allergic Rhinitis or Rhinoconjunctivitis, With Controlled Allergic Asthma

Conditions:   Rhinitis;   Rhinoconjunctivitis;   Asthma
Interventions:   Biological: DP/MG/14-1;   Biological: DP/MG/14-2
Sponsor:   Laboratorios Leti, S.L.
Recruiting – verified January 2015

View full post on ClinicalTrials.gov: asthma | received in the last 14 days